Hematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway

by Tesio, Melania, Tang, Yilang, Müdder, Katja, Saini, Massimo, von Paleske, Lisa, Macintyre, Elizabeth, Pasparakis, Manolis, Waisman, Ari, Trumpp, Andreas
Published 2015

Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion

by Lechman, Eric R., Gentner, Bernhard, van Galen, Peter, Giustacchini, Alice, Saini, Massimo, Boccalatte, Francesco E., Hiramatsu, Hidefumi, Restuccia, Umberto, Bachi, Angela, Voisin, Veronique, Bader, Gary D., Dick, John E., Naldini, Luigi
Published 2012

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients

by Baccelli, Irène, Stenzinger, Albrecht, Vogel, Vanessa, Pfitzner, Berit Maria, Klein, Corinna, Wallwiener, Markus, Scharpff, Martina, Saini, Massimo, Holland-Letz, Tim, Sinn, Hans-Peter, Schneeweiss, Andreas, Denkert, Carsten, Weichert, Wilko, Trumpp, Andreas
Published 2014

The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

by Aloia, Andrea, Petrova, Evgeniya, Tomiuk, Stefan, Bissels, Ute, Déas, Olivier, Saini, Massimo, Zickgraf, Franziska Maria, Wagner, Steve, Spaich, Saskia, Sütterlin, Marc, Schneeweiss, Andreas, Reitberger, Manuel, Rüberg, Silvia, Gerstmayer, Bernhard, Agorku, David, Knöbel, Sebastian, Terranegra, Annalisa, Falleni, Monica, Soldati, Laura, Sprick, Martin Ronald, Trumpp, Andreas, Judde, Jean-Gabriel, Bosio, Andreas, Cairo, Stefano, Hardt, Olaf
Published 2015